More evidence for the benefits of involvement of pharmacists in multidisciplinary teams

Just how much evidence do we need? The clinical effectiveness and cost effectiveness of pharmacist input at the ward level have recently been assessed in a systematic review and meta-analysis… again. The results showed that regular pharmacist input was most cost effective, reducing length-of-stay (mean = −1.74 days [95% CI: 2.76, −0.72], and increasing patient and/or carer satisfaction (Relative Risk (RR) = 1.49 [1.09, 2.03] at discharge). It seems way past time to simply accept that pharmacist involvement in multidisciplinary teams improves patient safety and satisfaction and is cost-effective when regularly provided throughout the ward stay. Read more here